GSK expands U.K. API plant; Sanofi recalls drug in Philippines;

> GlaxoSmithKline ($GSK) will spend up to £28 million ($47.3 million) to expand an active pharmaceutical ingredient plant in Montrose, U.K. Story

> Sanofi ($SNY) is voluntarily recalling three batches of transplant drug Thymoglobuline in the Philippines because of out-of-specification findings for the product. Story

> Japan's Daiichi Sankyo has asked a court in India to withdraw a stay on its sale of Ranbaxy Laboratories to Sun Pharmaceutical put in place to allow an investigation into allegations of insider trading ahead of the announced deal. Story

> India's Commerce Ministry reports that pharmaceutical exports rose 10.5% in April to $1.26 billion. Report

> Perrigo says it has started shipping its generic version of Meda's Astepro nasal spray after it and partner Impax Laboratories got FDA approval, even though they are involved in patent litigation with Meda over the product. Release

And Finally... The FDA plans to work more closely with regulators in Europe in hopes of improving drug quality in both continents. Story